Evidence map›Paper›PMID 38453949›Full record

ArticleNature communications2024

NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.

Ilya Tsukalov, Ildefonso Sánchez-Cerrillo, Olga Rajas, Elena Avalos, Gorane Iturricastillo, Laura Esparcia, María José Buzón, Meritxell Genescà, Camila Scagnetti, Olga Popova and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Ilya Tsukalov *Medicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Ildefonso Sánchez-Cerrillo *Immunology Unit from Hospital Universitario La Princesa, Instituto Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.
Olga RajasPneumology Unit from Hospital Universitario La Princesa, Madrid, Spain.
Elena AvalosPneumology Unit from Hospital Universitario La Princesa, Madrid, Spain.
Gorane IturricastilloPneumology Unit from Hospital Universitario La Princesa, Madrid, Spain.
Laura EsparciaMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
María José BuzónInfectious Diseases Department, Institut de Recerca Hospital Univesritari Vall d'Hebrón (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-4427-9413
Meritxell GenescàInfectious Diseases Department, Institut de Recerca Hospital Univesritari Vall d'Hebrón (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-6413-3812
Camila ScagnettiImmunology Unit from Hospital Universitario La Princesa, Instituto Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.
Olga PopovaMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Noa Martin-CófrecesMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Marta Calvet-MirabentMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Ana Marcos-JimenezMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.ORCID 0000-0002-7606-3580
Pedro Martínez-FletaMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Cristina Delgado-ArévaloImmunology Unit from Hospital Universitario La Princesa, Instituto Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.
Ignacio de Los SantosCIBER Infectious Diseases (CIBERINFECC), Instituto de Salud Carlos III, Madrid, Spain.
Cecilia Muñoz-CallejaImmunology Unit from Hospital Universitario La Princesa, Instituto Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.
María José CalzadaMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Isidoro González ÁlvaroRheumatology Department from Hospital Universitario La Princesa. Instituto de Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.
José Palacios-CalvoDepartment of Pathology, Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), Universidad de Alcalá. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Arantzazu AlfrancaImmunology Unit from Hospital Universitario La Princesa, Instituto Investigación Sanitaria-Princesa IIS-IP, Madrid, Spain.ORCID 0000-0002-3732-5816
Julio AncocheaPneumology Unit from Hospital Universitario La Princesa, Madrid, Spain.ORCID 0000-0001-7451-4133
Francisco Sánchez-MadridMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain.
Enrique Martin-GayoMedicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain. enrique.martin@uam.es.ORCID 0000-0002-2619-6086
Hospital Universitario de La Princesa · ESInstituto de Salud Carlos III · ESUniversidad Autónoma de Madrid · ESUniversitat Autònoma de Barcelona · ESUniversidad de Alcalá · ES

Funding

Comunidad de Madrid INMUNOVACTER REACT-EUComunidad de Madrid Inmunovacter REACT-UEMinisterio de Economía y Competitividad (Ministry of Economy and Competitiveness) PDC2021-121719-I00Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PID-2020-120412RB-I00Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2021-127899OB-I00Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) CIBERCVMinistry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) CIBERINFECC
6 · The paper itself

Abstract

Increased recruitment of transitional and non-classical monocytes in the lung during SARS-CoV-2 infection is associated with COVID-19 severity. However, whether specific innate sensors mediate the activation or differentiation of monocytes in response to different SARS-CoV-2 proteins remain poorly characterized. Here, we show that SARS-CoV-2 Spike 1 but not nucleoprotein induce differentiation of monocytes into transitional or non-classical subsets from both peripheral blood and COVID-19 bronchoalveolar lavage samples in a NFκB-dependent manner, but this process does not require inflammasome activation. However, NLRP3 and NLRC4 differentially regulated CD86 expression in monocytes in response to Spike 1 and Nucleoprotein, respectively. Moreover, monocytes exposed to Spike 1 induce significantly higher proportions of Th1 and Th17 CD4 + T cells. In contrast, monocytes exposed to Nucleoprotein reduce the degranulation of CD8 + T cells from severe COVID-19 patients. Our study provides insights in the differential impact of innate sensors in regulating monocytes in response to different SARS-CoV-2 proteins, which might be useful to better understand COVID-19 immunopathology and identify therapeutic targets.

Indexed as

COVID-19InflammasomesCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsHumansMonocytesNF-kappa B p50 SubunitNLR Family, Pyrin Domain-Containing 3 ProteinNucleoproteinsSARS-CoV-2Calcium-Binding ProteinsCARD Signaling Adaptor ProteinsInflammasomesNF-kappa B p50 SubunitNFKB1 protein, humanNLRC4 protein, humanNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanNucleoproteins

Identifiers

PMID38453949
PMCPMC10920883
OpenAlexW4392544641

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.